Nemolizumab Under Review for Prurigo Nodularis, Atopic Derma

Nemolizumab is a humanized monoclonal antibody that antagonizes IL-31 receptor alpha, blocking the signaling of IL-31.

Related Keywords

Baldo Scassellati Sforzolini , Drug Administration , Biologics License Applications , Peak Pruritus Numerical Rating Scale , Eczema Area , Severity Index ,